Treatment of Blepharospasm with Botulinum Toxin

https://doi.org/10.1016/0002-9394(85)90228-4Get rights and content

In 43 patients (81 eyes) with blepharospasm resistant to other forms of therapy, 149 outpatient injections of botulinum A toxin were given into the orbicularis oculi muscle. Subsequent follow-up periods ranged from ten to 210 days. Orbicularis oculi spasm, eyelid forced closure, and eyebrow spasm all decreased substantially over the first ten days following the initial injection. Patients with essential blepharospasm, hemifacial spasm, or previous surgery all responded in a similar fashion. This beneficial effect was transient, however, and additional treatment was required for sustained relief. Twenty-five patients received multiple injections with a mean interval of 65 days. Results of second and third injections were similar to the first in rapidity of onset and duration of effect. Complications were local, mild, and transient, and no systemic side effects were noted.

References (16)

There are more references available in the full text version of this article.

Cited by (85)

  • Chemodenervation

    2024, Minimally Invasive Aesthetic Surgery
  • Esthetics and dermatologic pharmaceuticals. anatomy and clinical implications for cosmetic surgery.

    2014, Esthetic Dentistry: A Clinical Approach to Techniques and Materials
  • Esthetics and dermatologic pharmaceuticals

    2014, Esthetic Dentistry: A Clinical Approach to Techniques and Materials, Third Edition
  • Procedures Offered in the Medical Spa Environment

    2008, Dermatologic Clinics
    Citation Excerpt :

    Botulinum toxin A (BOTOX, Allergan, Irvine, CA) is a purified complex of the neurotoxin produced from the bacterium Clostridium botulinum. In the mid-1980s, clinical reports began to emerge regarding the therapeutic effects of botulinum toxin in blepharospasm and strabismus22–26 and, in 1989, the FDA approved BOTOX for these indications. In 1992, the first published cosmetic study reported that 16 of 17 subjects had a marked improvement of glabellar wrinkles after BOTOX injections into the corrugators or brow furrows and the result lasted 3–11 months.27

  • Botulinum toxin management of upper facial rhytidosis and blepharospasm

    2005, Otolaryngologic Clinics of North America
    Citation Excerpt :

    Botulinum toxin is now the mainstay of treatment for blepharospasm. The original articles on its use in blepharospasm [16,20–22] proved the effectiveness of botulinum toxin with a duration of 3 months in nonoperated patients and 4 to 6 months in previously operated patients. As described, botulinum toxin temporarily blocks the motor end plate by preventing the release of acetylcholine.

View all citing articles on Scopus

Reprint requests to Edward G. Buckley, M.D., Duke University Eye Center, P.O. Box 3802, Durham, NC 27710.

View full text